Subtotal: KSh12,500.00
Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) designed to stimulate the body’s natural production of growth hormone. Unlike growth hormone itself, Tesamorelin works by signaling the pituitary gland to release endogenous growth hormone, leading to increased IGF-1 production and downstream metabolic effects.
Tesamorelin is one of the few peptides in its category with an FDA-approved medical use. It is approved for reducing excess abdominal visceral fat in adults with HIV-associated lipodystrophy. It is not approved as a general weight-loss medication.
Tesamorelin binds to GHRH receptors in the pituitary gland and stimulates the release of natural growth hormone.
✔ Encourages natural GH secretion
✔ Supports IGF-1 production
✔ Maintains physiological hormone signaling
✔ Studied for reducing deep abdominal fat
✔ Investigated for improving body composition
✔ Explored in metabolic health research
✔ Influences lipid metabolism
✔ Supports fat utilization pathways
✔ May impact insulin and glucose-related pathways
Tesamorelin has been studied extensively for reducing visceral adipose tissue (VAT), the fat surrounding internal organs. Clinical studies in HIV-associated lipodystrophy have demonstrated meaningful reductions in abdominal visceral fat.
Rather than supplying growth hormone directly, Tesamorelin stimulates natural GH release from the pituitary gland.
Researchers have explored its effects on lean body mass, fat distribution, and overall body composition.
Tesamorelin is frequently discussed within performance and longevity communities because of its relationship with growth hormone and IGF-1 pathways, although many of these uses remain investigational.
Growth hormone pathways play a role in aging research, making Tesamorelin a peptide of interest in longevity-focused communities.
Unlike synthetic growth hormone:
✔ Stimulates your body’s own GH production
✔ Works through natural endocrine pathways
✔ Increases IGF-1 indirectly
✔ Preserves normal feedback mechanisms
🧬 Growth Hormone-Releasing Hormone (GHRH) Analog
🔥 Visceral Fat Research Focus
⚡ Supports Natural GH Release
💪 Body Composition Research
🌱 Longevity & Metabolic Health Interest
🔬 Advanced Peptide Innovation
Tesamorelin is a synthetic GHRH analogue that stimulates the release of natural growth hormone from the pituitary gland.
No. Tesamorelin is not growth hormone. It signals the body to produce its own growth hormone.
In the United States, Tesamorelin is approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for general weight-loss management.
Approved formulations are administered via subcutaneous injection.
At Oak Peptides Pharmaceuticals, we provide premium-quality peptide products backed by scientific education, product quality, and dedicated customer support.
✔ Premium Quality Standards
✔ Advanced Biotechnology Solutions
✔ Nationwide Delivery Across Kenya
✔ Professional Customer Support
✔ Trusted Peptide Supplier
Reviews
There are no reviews yet.